openPR Logo
Press release

๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ to Achieve a USD 61.93 Billion Valuation by 2030

๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

The total ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ was valued at USD 22.45 Billion in 2023 and is expected to reach USD 61.93 Billion by 2030 at a CAGR of 15.6% during the forecast period.

๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

The drug discovery services market is experiencing significant growth, driven by the increasing demand for new therapeutics and the rising need for outsourcing research and development services to optimize costs. Pharmaceutical companies are increasingly collaborating with Contract Research Organizations (CROs) to streamline their drug discovery processes and improve profitability. With advancements in biologics and biosimilars, along with innovations in AI-powered drug discovery, the market is set to expand further as companies seek efficient solutions for the development of new drugs.

๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ฌ ๐‰๐ฎ๐ฌ๐ญ ๐š ๐‚๐ฅ๐ข๐œ๐ค ๐€๐ฐ๐š๐ฒ! https://www.maximizemarketresearch.com/request-sample/6672/

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

Key drivers for the drug discovery services market include growing investments in pharmaceutical and biopharmaceutical R&D, the rising demand for biologics and biosimilars, and the need for cost-effective solutions to streamline the drug discovery process. The increasing reliance on outsourced services, such as analytical testing and AI-based drug discovery tools, is also a major contributor to market growth, as it allows pharmaceutical companies to focus on core competencies while reducing development time and expenses.

๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

The drug discovery services market is witnessing several trends, including the growing use of artificial intelligence to optimize drug research processes and predict potential outcomes before production. Another trend is the shift toward biologics and biosimilars, which require more specialized testing services. Additionally, the pharmaceutical sector is increasingly focusing on rare diseases and orphan drug research, providing new revenue streams for CROs and drug discovery service providers.

๐๐ž๐ž๐ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง? ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐€๐›๐จ๐ฎ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž + ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐‡๐ž๐ซ๐ž: https://www.maximizemarketresearch.com/inquiry-before-buying/6672/

๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:

The increasing need for specialized drug development services, particularly for biologics and biosimilars, presents significant growth opportunities for CROs. The rising demand for integrated outsourcing services, combined with advancements in AI and data analytics, offers potential for companies to develop more targeted and efficient drug discovery solutions. Emerging markets, with growing healthcare investments, also provide new avenues for market expansion.

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ?

North America dominates the drug discovery services market, owing to the presence of major pharmaceutical companies and advanced R&D infrastructure. Europe follows closely due to significant investment in healthcare and biopharmaceutical development. Meanwhile, the Asia-Pacific region is experiencing rapid growth, driven by increasing R&D activities, rising healthcare spending, and the emergence of local CROs, making it a key region for market expansion in the coming years.

๐‚๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐จ ๐ฉ๐ž๐ž๐ค ๐ข๐ง๐ฌ๐ข๐๐ž? ๐†๐ซ๐š๐› ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ฐ:๏ปฟ https://www.maximizemarketresearch.com/request-sample/6672/ ๏ปฟ๏ปฟ

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

by Process

Target Selection
Target Validation
Hit-to-Lead identification
Lead Optimization
Candidate Validation

by Type

Medicinal Chemistry
Biology Services
Drug Metabolism and Pharmacokinetics

by Therapeutic Area

Oncology
Neurology
Cardiovascular Diseases
Respiratory Diseases
Diabetes and Other Therapeutic Areas

by End-User

Pharmaceutical & Biotechnology companies
Academic Institutes
Other End Users (small CROs, IVD companies, and clinical laboratories)

๐–๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ž?

1. Thermo Fisher Scientific (US)
2. Merck (US)
3. GE Healthcare (US)
4. Pharmaceutical Product Development, LLC. (Ppd) (US)
5. Covance (US)
6. Genscript Biotech Corporation (US)
7. Laboratory Corporation of America Holdings (US)
8. SRI International (US)
9. BioDuro (US)
10. Cullgen (US)
11. Nanosyn (US)
12. Radyus Research (US)
13. Visikol Inc (US)
14. Aurobindo Pharma (India)
15. Dr. Reddy's Laboratories (India)

๐†๐ž๐ญ ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐Ž๐ง ๐“๐ก๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐Ž๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.maximizemarketresearch.com/market-report/global-drug-discovery-services-market/6672/ ๏ปฟ๏ปฟ๏ปฟ๏ปฟ

๐Š๐ž๐ฒ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ง๐ ๐ฌ:

Past Market Size and Competitive Landscape
Coffee Beans Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Coffee Beans Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐จ๐ฎ๐ซ ๐ญ๐จ๐ฉ-๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ญ๐ซ๐ž๐ง๐๐ฌ:

โ™ฆ Surety Market https://www.maximizemarketresearch.com/market-report/surety-market/185094/

โ™ฆ Barefoot Shoes Market https://www.maximizemarketresearch.com/market-report/barefoot-shoes-market/186746/

โ™ฆ Medical clothing Market https://www.maximizemarketresearch.com/market-report/medical-clothing-market/147694/

โ™ฆ Healthcare Information System Market https://www.maximizemarketresearch.com/market-report/healthcare-information-system-market/124949/

โ™ฆ Contrast Media Market https://www.maximizemarketresearch.com/market-report/global-contrast-media-market/54969/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ๐ƒ๐ซ๐ฎ๐  ๐ƒ๐ข๐ฌ๐œ๐จ๐ฏ๐ž๐ซ๐ฒ ๐’๐ž๐ซ๐ฏ๐ข๐œ๐ž๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ to Achieve a USD 61.93 Billion Valuation by 2030 here

News-ID: 3708168 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD

Ultrafiltered Milk Market Valued at USD 8.36 Billion in 2024, Anticipated to Grow at 4.6% CAGR Through 2032
Ultrafiltered Milk Market Valued at USD 8.36 Billion in 2024, Anticipated to Gro โ€ฆ
The Ultrafiltered Milk Market size was valued at USD 8.36 Billion in 2024 and the total Ultrafiltered Milk revenue is expected to grow at a CAGR of 4.6% from 2025 to 2032, reaching nearly USD 11.99 Billion. Ultrafiltered Milk Market Overview: Ultrafiltered milk is gaining increasing attention in the dairy and functional food sectors thanks to its enhanced nutritional profile. Through a specialized membrane filtration process, ultrafiltration concentrates higher-molecular weight componentsโ€ฆ
Bath Towel Market to Grow from USD 10.46 Billion by 2032 at a CAGR of 6.7 %
Bath Towel Market to Grow from USD 10.46 Billion by 2032 at a CAGR of 6.7 %
The Bath Towel Market size reached USD 6.23 Bn in 2024 and is expected to reach USD 10.46 Bn by 2032, growing at a CAGR of 6.7 % during the forecast period. Bath Towel Market Overview: The bath towel industry is witnessing steady expansion, fueled by consumers' increasing focus on hygiene, comfort, and home aesthetics. High demand for plush, absorbent towels made of luxury materials such as Egyptian cotton, Turkish cotton,โ€ฆ
Carob Market to Reach USD 374.76 Million by 2032 Growing at a 5.3% CAGR
Carob Market to Reach USD 374.76 Million by 2032 Growing at a 5.3% CAGR
The global Carob Market was valued at USD 247.92 million in 2024 and is projected to reach USD 374.76 million by 2032, expanding at a compound annual growth rate (CAGR) of 5.3% during the forecast period from 2025 to 2032. Carob Market Overview: The carob market is experiencing significant growth, driven by its increasing popularity as a natural sweetener and plant-based alternative to chocolate. Derived from the seed pods of the carobโ€ฆ
Welding Electrode Market Expected To Reach USD 11.27 Bn by 2032
Welding Electrode Market Expected To Reach USD 11.27 Bn by 2032
The Welding Electrode Market size was valued at USD 5.70 Billion in 2024 and the total Welding Electrode revenue is expected to grow at a CAGR of 8.9 % from 2025 to 2032, reaching nearly USD 11.27 Billion. Welding Electrode Market Overview: The Welding Electrode Market is evolving as a critical segment within the global manufacturing and construction industries. Welding electrodes are essential consumables that enable reliable and efficient joining ofโ€ฆ

All 5 Releases


More Releases for CROs

Specialty Cros Market Is Booming So Rapidly 2025-2032 -CROs market include Charl โ€ฆ
The latest report (2025-2032) on the Specialty Cros Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/1627 Focused on growth and future opportunities,โ€ฆ
Specialty Cros Market Set to Witness Significant Growth by 2025-2032 | CROs mark โ€ฆ
Latest Qualitative Research Report on the Specialty Cros Market 2025, published by Coherent Market Insights, provides valuable insights into both regional and global markets projected to grow in value from 2025 to 2032. The comprehensive research explores into the evolving Market's dynamics, value chain analysis, prominent investment areas, competitive landscape, drivers and constraints, regional outlook, and key market segments. It's also provides the industry overview with growth analysis and historicalโ€ฆ
Global CROs Services Market Size - Forecasts to 2026
The findings reviewed by GME stated that the Global Contract Research Organization (CROs) Services Market will expand at a CAGR value of 9.62% to reach USD 85.61 billion by 2026 from USD 51.25 billion by 2021. The market is likely to be driven by the growing number of clinical testing, growing incidence of rare diseases, and rising investments in biopharmaceutical and pharmaceutical R&D activities. Browse 155 Market Data Tables and 115โ€ฆ
Global CROs Services Market Insights, Forecast to 2025
Market Research Report Store offers a latest published report on CROs Services Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 158 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.marketresearchreportstore.com/reports/435591/global-cros-services-market-insights ย  Aย contract research organizationย (CRO) is a company thatโ€ฆ
11-26-2010 | Health & Medicine
CROS NT
CROS NT WINS A "BEST PRESENTATION" AT PhUSE 2010
Verona, Italy (26 NOVEMBER 2010) โ€“ Stefano Vezzoli, part of CROS NTโ€™s highly qualified and experienced biostatistics team, won Best Presentation in the area of Statistics and Pharmacokinetics at the Pharmaceutical Users Software Exchange (PhUSE) conference in Berlin, Germany. Vezzoliโ€™s presentation was titled โ€œInference for the Location Shift in 3x3 Crossover Studies: the Median-Scaling Methodโ€. Vezzoliโ€™s Paper Abstract In the case of non-normal study outcomes, a nonparametric approach may be usedโ€ฆ
07-29-2010 | Health & Medicine
CROS NT
CROS NT appoints new Vice President for Germany
CROS NT (CRO) announces the appointment of Frank Freischlรคger as Vice President (VP) for CROS DE GmbH, the German affiliate of CROS NT. As a VP at CROS DE he will be responsible for all aspects, which is focused on successful clinical trial activities. CROS is very excited to adding Mr. Freischlรคger's depth of industry expertise to the CROS team. "Bringing someone of Frank's knowledge to an already strong teamโ€ฆ